Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
39.53
+1.56 (4.11%)
At close: Sep 2, 2025, 4:00 PM
40.00
+0.47 (1.19%)
After-hours: Sep 2, 2025, 7:52 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $7.39 billion as of September 2, 2025. Its market cap has increased by 3.89% in one year.
Market Cap
7.39B
Enterprise Value
5.39B
1-Year Change
3.89%
Ranking
Category
Stock Price
$39.53
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $7.39B, an increase of 349.35%. That is a compound annual growth rate of 31.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 7.10B | -12.19% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |